Best Practices

Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy




A supplement to Clinical Neurology News. This supplement was supported by Talecris Biotherapeutics.



• Diagnosing CIDP

• Therapeutic Options

• The ICE Study

• Best Practices: Key Takeaways


Faculty/Faculty Disclosures

Vera Bril, MD
Department of Neurology
University Health Network
Toronto, Ontario, Canada
Dr. Bril was a consultant with Talecris Biotherapeutics.


Copyright © 2008 Elsevier Inc.


To view the supplement, click the image above.

Recommended for You

News & Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge

Next Article: